baber/WOPTO huggingface dataset:
Patent NZ-518648-A (NZ)
Title: A drainage pipe convering kit for use during building or floor construction
Inventor: HOWSON LESLIE LAWRENCE
IPC: E04D13/04
Filed: 2000-09-25
Abstract: An accessory for use in construction includes a conduit (12) that has an inlet end (34) portion and an outlet end (18) portion. The outlet end (18) portion is mountable on a drainage pipe (22) so that the conduit (12) and the drainage pipe (22) are in fluid communication with each other. A removable closure member (40) is mounted on the inlet end (34) portion to close the conduit (12) when not in use or during building construction, so that ingress of material or detritus into the drainage pipe (22) is inhibited.
Patent NZ-519975-A (NZ)
Title: Substituted pyrrole mannich bases to combat pain and allergic reactions
Inventor: GERLACH MATTHIAS
IPC: C07D207/00
Filed: 2000-12-20
Abstract: The invention relates to substituted pyrrole Mannich bases, a method for the production thereof, medicaments containing said compounds, and the use of said compounds in the production of medicaments.
Patent NZ-521384-A (NZ)
Title: Process and device for aerating a liquid with gas
Inventor: SCHERZINGER BERNHARD
IPC: B03D1/24
Filed: 2002-09-13
Abstract: A process for aerating a liquid with gas, said process being adapted for use in the process for separating impurities from suspensions by means of flotation, the process comprising the injection of liquid through a nozzle into a volume of gas, whereby part of the gas volume is sucked in by the vacuum generated by the liquid injected and carried along together with the liquid at the same time. Also described is a device used for aerating a gas.
Patent NZ-521784-A (NZ)
Title: Bile secretion promoting composition
Inventor: UENO RYUJI
IPC: A61K9/08
Filed: 2001-04-05
Abstract: Disclosed is the use of a 15-keto-prostaglandin compound, particularly of formula (I), for producing a pharmaceutical composition for treatment of a subject having a disease or condition associated with bile secretion disorder, and for promoting bile secretion of a liver to be transplanted in a liver transplantation process.
Patent NZ-524490-A (NZ)
Title: Liposomal encapsulated taxane
Inventor: RAHMAN AQUILAR
IPC: A61P11/00
Filed: 1999-06-29
Abstract: Disclosed are liposome compositions comprising, a liposome-forming material, a tocopherol, and a taxane or derivative thereof. Particular examples of taxanes include paclitaxel, and a particular liposome-forming material disclosed is cardiolipin. (62) Divided out of 502950
Patent NZ-524591-A (NZ)
Title: Transport locking for a vibrating feeder of a mobile crushing unit
Inventor: NUORA MARKO JUHANI
IPC: B02C21/02
Filed: 2002-08-26
Abstract: A transport locking arrangement is disclosed for a vibrating feeder of a mobile crushing unit, the transport locking arrangement utilizing the downward rotatable sidewalls of a feeder hopper of the vibrating feeder that are hingedly mounted on the framework (1) of the crushing unit, whereby the sidewalls in their lower position are adapted to lock the vibrating feeder substantially rigidly to the framework of the crushing unit.
Patent NZ-525653-A (NZ)
Title: New pharmaceutical compositions containing epinastine and pseudoephedrine
Inventor: ABELAIRA SARA
IPC: A61P11/02
Filed: 2001-09-28
Abstract: A bilayer tablet wherein: the first layer A comprises a decongestant effective amount of pseudoephedrine or pharmaceutically acceptable salt thereof which allows sustained release of pseudoephedrine; and the second layer B comprises an antihistaminic effective amount of epinastine or a pharmaceutically acceptable salt thereof which allows immediate release of epinastine. Also described is the use of the bilayer tablet in the treatment allergic rhinitis, allergic congestion of the Eustachian tubes and/or other diseases from allergic origin deserving the administration of antihistamine and decongestant drugs, such as the common cold, and for symptomatic relief associated with cough, cold and flu symptoms.
Patent NZ-528279-A (NZ)
Title: Preparation of modified wood
Inventor: MATSUMARA KAZUYUKI
IPC: B05D7/00
Filed: 2003-09-18
Abstract: A method for preparing modified wood where wood is treated with an aqueous water repellent [I] and with an emulsion water repellent [II]. The aqueous water repellent [I] comprises a product obtained from co-hydrolytic condensation of: - an oragnosilicon compound of formula (1) : (R1)a(OR2)bSiO(4-a-b)/2, - an amino-containing alkoxysilane of formula (2): R3R4NR5-SiR6n(OR2)3-n, in the presence of an organic or inorganic acid. The emulsion water repellent [II] is a trialklylsiloxysilicate emulsion water repellent obtained by polymerizing: - an organodisiloxane of formula (3): R73Si-O-SiR73 and - at least one of a tetraalkoxysilane of formula (4): Si(OR7)4, in such a proportion that the molar ratio of trialkylsiloxy units: R7SiO0.5 of formula (3) to tetrafunctional units: SiO4/2 in formula (4) may be in range of 0.5 to 2.0 in an aqueous solution containing a surfactant and water at a temperature of 30 to 90oC.
Patent NZ-528844-A (NZ)
Title: A container having pressure responsive panels
Inventor: MELROSE DAVID MURRAY
IPC: B65D23/12
Filed: 2003-10-10
Abstract: A container suitable for containing liquid and having at least one controlled deflection flex panel for accommodating pressure change induced in the container, said flex panel having longitudinal and transverse extents defining a plane of said flex panel, said flex panel having a flexure initiator region and at least one flexure region positioned longitudinally away from said flexure initiator region, said flexure initiator region having a lesser amount of arc projecting away from said plane than said flexure region, said regions merging together within the panel so that said initiator region can flex inwardly relative to said plane and wherein in response to pressure changes the amount of arc changes and causes said flexure region to progressively flex in response to increasing pressure change in the container.
Patent NZ-531871-A (NZ)
Title: Anticonvulsant derivatives such as topiramate useful for the treatment of restless limb syndrome and periodic limb movement disorder
Inventor: ABUZZAHAB FARUK S
IPC: A61K31/7004
Filed: 2002-09-23
Abstract: Anticonvulsant derivatives, particularly topiramate, for treating restless limb syndrome, more particularly restless legs syndrome, restless arms syndrome, periodic limb movement disorder and associated sleep disturbances, regardless of underlying cause.
Patent NZ-532294-A (NZ)
Title: Synergistic mix of a peroxide source, bioadhesive and an extended release polymer that releases and maintains a very low concentration of peroxide over an extended period of time to provide benefits of oxygen release, while decreasing pH
Inventor: BOLOGNA WILLIAM J
IPC: A61P31/04
Filed: 2002-10-28
Abstract: A pharmaceutical vaginal composition for treating or preventing vaginal infections is described. The composition includes a synergistic mix of a bioadhesive, extended release formulation that decreases the pH and that contains a peroxide in an amount sufficient to increase oxygen concentration without sterilising the vagina or substantially killing the normally-desired local vaginal flora.
Patent NZ-534981-A (NZ)
Title: Hair treatment/drying cap with particulate material to release heat
Inventor: MCJORROW GAIL
IPC: A45D8/40
Filed: 2004-08-30
Abstract: Cap 2 has outer and inner layers forming an enclosed internal space 10 containing particulate heat responsive medium, typically wheat or corn. It is placed on a user's head to transfer heat from the particulate to the user's hair.
Patent NZ-535425-A (NZ)
Title: Anti-alphavbeta6 antibodies
Inventor: VIOLETTE SHELIA M
IPC: G01N33/574
Filed: 2003-03-13
Abstract: Disclosed are monoclonal antibodies that specifically bind to alphavbeta6 and inhibits the binding of alphavbeta6 to latency associated peptide (LAP) with an IC50 value lower than that of antibody 10D5. Also disclosed is the use of the antibody to treat a disease mediated by alphavbeta6.
Patent NZ-535723-A (NZ)
Title: Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
Inventor: KONRADI ANDREI W
IPC: A61P19/02
Filed: 2003-05-27
Abstract: N-[2-N',N'-diethylamino-5-aminosulfonylphenylpyrimidin-4-yl]-p-carbomyloxy-phenylalanine compounds which inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by alpha-4 integrins, where the alpha-4 integrin is preferably VLA-4 are disclosed. These compounds include those of formula (I), wherein each X is independently fluoro, chloro or bromo; p is 0 or an integer from 1-3; R1 is selected from the group consisting of methyl and ethyl; R2 is selected from the group consisting of lower alkyl, lower alkenyl, and lower alkylenecycloalkyl. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis, and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
Patent NZ-535810-A (NZ)
Title: Biomaterial precipitated from cyclodextrin, an anionic polymer component and an amphiphilic ammonium type compound
Inventor: SZENTE LAJOS
IPC: A23L35/00
Filed: 2003-04-17
Abstract: Disclosed is a precipitate, comprising at least an anionic polymeric component which is as such soluble in water and an amphiphilic ammonium-type component comprising a cationic surfactant, which precipitate is obtained by a process including the following steps: 1. contacting the anionic polymeric component and a cyclodextrin component in an aqueous medium, and 2. adding to the mixture obtained in step 1 said amphiphilic ammonium-type component, wherein said component are present in amounts effective to form said precipitate. The precipitate may further comprise materials or agents and is useful for the sustained or controlled release of said materials or agents.
Patent NZ-536907-A (NZ)
Title: Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
Inventor: ZELDIS JEROME B
IPC: A61K31/4035
Filed: 2003-05-16
Abstract: Disclosed herein is a use of a compound of formula (I) or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, for the manufacture of a medicament for the treatment of prostrate cancer, metastatic melanoma and multiple myeloma, wherein the medicament is administered cyclically.
Patent NZ-538632-A (NZ)
Title: Juice purification system
Inventor: SANDERS DAVID
IPC: C13B20/00
Filed: 2003-08-13
Abstract: A method of purifying juice obtained from plant material by exposing the juice to a gas having characteristics which allow transfer of at least one substance from the juice to the gas to reduce the amount of the substance with the juice. A juice purification system for carrying out the process and the products of the process.
Patent NZ-543112-A (NZ)
Title: Reclosable package with closure means embedded in the rigid base member
Filed: 2005-10-20
Abstract: A reclosable package comprises a rigid base member. A product is placed on the rigid base member and a cover film is placed over the product and sealed to the rigid base member all around the product. Removable reclosure means made of the same material as the rigid base member are embedded in the rigid base member and the cover film is secured to the removable reclosure means.
Patent NZ-554026-A (NZ)
Title: Electronic device with three movable layers
Inventor: SANTOS THEODORE R
IPC: H04M1/02
Filed: 2005-09-20
Abstract: An electronic device is provided, which includes: a first module layer movable in a first direction; a second module layer movably connected relative to the first module layer; a third module layer movably connected relative to the second module layer and movable in a second direction; and a locking member engageable with the third module layer to prevent movement in the second direction during movement of the first module layer in the first direction. A method of controlling relative movement between movable layers of an electronic device is also provided.
Patent NZ-554954-A (NZ)
Title: High discharge capacity lithium battery
Inventor: MARPLE JACK W
IPC: H01M50/463
Filed: 2005-04-01
Abstract: A lithium/iron disulfide electrochemical battery cell with a high discharge capacity. The cell has a lithium negative electrode, an iron disulfide positive electrode and a nonaqueous electrolyte. The iron disulfide of the positive electrode has a controlled average particle size range which allows the electrochemical cells to exhibit desired properties in both low and high rate applications. In various embodiments, the iron disulfide particles are wet milled, preferably utilizing a media mill or milled utilizing a non-mechanical mill such as a jet mill, which reduces the iron disulfide particles to a desired average particle size range for incorporation into the positive electrode.
Patent NZ-561618-A (NZ)
Title: A bait for omnivorous feral animals with a wax and tallow core containing active agent and uses thereof
Inventor: STAPLES LINTON DREW
Filed: 2007-09-18
Abstract: A bait for omnivorous feral animals is disclosed. The bait comprises a core, which is in physical contact with a solid or semi-solid carrier material. The core comprises a mixture of wax and tallow, and contains an active agent, where the core is located within the solid or semi-solid carrier material.
Patent NZ-564759-A (NZ)
Title: GPCR agonists
Inventor: FYFE MATTHEW COLIN THOR
IPC: C07D211/36
Filed: 2006-06-29
Abstract: Disclosed are compounds of formula (I), wherein Z is phenyl or 5-6 membered heteroaryl, which is para-substituted, W-X-Y is a 4-5 atom chain, G is a substituted nitrogen or carbon atom and the remaining substituents are as defined in the specification. The compounds are G-protein coupled receptor (GPCR) agonists useful in the treatment of obesity and diabetes. Also disclosed is a pharmaceutical composition comprising a compound of formula (I). Exemplary compounds are: 4-[3-( 4-Acetylamino-3-fluoro-phenoxy)propyl]piperidine-1- carboxylic acid tert-butyl ester; 4-[3-(3-Fluoro-4-propionylaminophenoxy)-propyl]piperidine-1-carboxylic acid tert-butyl ester; and 4-{ 3-[3-Fluoro-4-(pyrrolidine-1-carbonyl)phenylamino ]propyl} -piperidine-1-carboxylic acid tert- butyl ester.
Patent NZ-565356-A (NZ)
Title: A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
Inventor: LABRIOLA RAFAEL ALBERTO
IPC: A61K31/675
Filed: 2006-05-12
Abstract: A crystalline trihydrate form of the Zoledronic acid is disclosed, which is characterized by its X-rays diffractogram as well as by its spatial atomic distribution in the crystalline network and its thermal analysis curves. Also disclosed is a method to obtain this crystalline form, which includes the synthesis of the corresponding acid; and a pharmaceutical composition comprising this crystalline form.
Patent NZ-577299-A (NZ)
Title: Metered drop bottle for dispensing single microlitre drops of a liquid.
Inventor: GOKHALE SATISH MADHUKAR
IPC: B65D47/18
Filed: 2007-12-07
Abstract: A metered drop bottle is disclosed for dispensing microliter drops of a liquid. The metered drop bottle comprises: (a) A bottle (4) with a flexible portion on the walls that decreases the internal volume by a fixed amount. (b) A plunger (6) with a fixed stroke for depressing the flexible portion. (c) A nozzle tip (3B) having an internal (3 ID) and/or outer (3 OD) diameter no more than 1.2 mm.
Patent NZ-581232-A (NZ)
Title: Instrument for use in fluid with mixing element in form of strap connected to inside of container
Inventor: WILSON ALLAN WALTER
IPC: B01F23/00
Filed: 2007-11-14
Abstract: An instrument is disclosed for use with fluid and includes a mixing element and a container to hold the fluid to be mixed. The mixing element includes a sensor that assists to measure a parameter of the fluid. The mixing element is driven by a means that is not physically connected to the mixing element, typically an electromagnetic coil. The mixing element is in the form of a strap attached to the inside of the container. (62) Divided Out of 563464
Patent NZ-585898-A (NZ)
Title: Method for producing semi-mature dendritic cells and uses thereof
Inventor: FELZMANN THOMAS
IPC: C12N5/0784
Filed: 2008-12-12
Abstract: Disclosed is a pharmaceutical preparation comprising partially matured dendritic cells obtained by a method comprising the steps of: a) providing immature dendritic cells or precursor cells thereof or partially matured dendritic cells obtained by contacting immature dendritic cells with at least one dendritic cell maturation agent to produce partially matured dendritic cells as defined by their capacity to secrete IL-12, b) manipulating the cells of step a), in particular the partially matured dendritic cells releasing IL-12 of step a), to (i) over-express at least one immune molecule capable of maintaining the T-Iymphocyte stimulatory capacity of dendritic cells characterised by continued IL-12 secretion for at least 24 hours, preferably at least 48 hours, and selected from the group consisting of CD40L by introducing nucleic acid molecules encoding for said at least one molecule; and/or (ii) inhibit or prevent the expression of at least one T-Iymphocyte suppressive molecule acting within dendritic cells exposed to a primary maturation agent or being released from dendritic cells exposed to a primary maturation agent and being selected from the group consisting of interleukin 10 (IL-10), indoleamine 2,3- dioxygenase (IDO), and the genes given in the tables 3, 4 and/or 5 of the specification, by knocking out the gene or a fragment thereof encoding said at least one T-Iymphocyte suppressive molecule or by introducing nucleic acid molecules, preferably ribonucleic acid molecules, to inhibit or prevent the expression of the at least one T-Iymphocyte suppressive molecule that is active within the dendritic cell or is delivered from the dendritic cells to T-cells.
Patent NZ-587089-A (NZ)
Title: Plant health composition
Inventor: WILHELM RONALD
IPC: A01N35/04
Filed: 2009-02-04
Abstract: Disclosed herein is a method for improving the yield and/or improving the vigour and/or increasing the tolerance or resistance to abiotic stress factors of at least one plant variety, comprising treating the plant and/or the locus where the plant is growing or is intended to grow with N-(3',4' ,5'-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxamide, where improving the yield and improving the plant vigour and increasing the plant's tolerance or resistance to abiotic stress factors are independent of the pesticidal action of said caboxamide, and where treating the plant and/or the locus where the plant is growing or is intended to grow does not encompass treating the plant propagules.
Patent NZ-589714-A (NZ)
Title: Led lighting fixture coaxially supported above pole with directional illumination
Inventor: WILCOX KURT S
IPC: F21S4/00
Filed: 2009-05-22
Abstract: 589714 Disclosed is an LED lighting fixture for outdoor applications requiring floodlighting and good weather and heat protection of the electronics. The LED lighting fixture includes a support structure having a horizontal cross-dimension and including an upwardly/outwardly-extending upper portion. A top structure is coaxially attached to the upper portion of the support structure and extends outwardly beyond the support structure. The top structure has a bottom surface facing the support structure and having a peripheral portion which is substantially perpendicular to the support structure axis and surrounds a non-peripheral portion. A plurality of LED emitters are positioned on the peripheral portion in an annular configuration for emitting light in downward direction substantially outside of the horizontal cross-dimension of the support structure and allowing only minimal light onto the support structure. The support structure's upper portion is formed by at least one upwardly and outwardly-extending arm positioned with its minimal dimensions in a way of the light such that the upper portion of the support structure permits a through passage of light directed across the greatest top-structure horizontal dimension toward the preferential side from LED emitters positioned farthest away. A subset of the emitters each having associated LED lensing is configured for distribution of light from the emitter in off-axial direction with respect to the emitter axis toward a preferential side, thereby to widen an outward and downward illumination angle or to facilitate illumination in a common downward lateral direction.
Patent NZ-590368-A (NZ)
Title: Key management in a wireless network using primary and secondary keys
Inventor: MCCULLOUGH JEFF D
IPC: H04L9/12
Filed: 2011-01-07
Abstract: A method of obtaining a new primary encryption key when decryption of a received encrypted message fails and a node of a wireless communications network are disclosed. The node (114, 116) is remote from a master node of the wireless communications network (120) and the master node and the node communicate via the wireless communications network. The node comprises a wireless communications interface for communicating via the wireless communications network; a primary encryption key for encrypting and decrypting messages in accordance with a symmetric key encryption algorithm; a secondary encryption key for encrypting and decrypting messages in accordance with the symmetric key encryption algorithm; and a processor. The processor operates to receive an encrypted message from the master node via the wireless communications interface; attempt to decrypt the received encrypted message using the primary encryption key; if the attempt to decrypt the received encrypted message using the primary encryption key fails, attempt to decrypt the received encrypted message using the secondary encryption key; and if the attempt to decrypt the received encrypted message using the secondary encryption key fails, receive a command transmitted by a source local to the node to change the secondary encryption key; change the secondary encryption key in response to the command; and use the changed secondary encryption key to perform encrypted communications with the master node via the wireless communications interface to obtain a new primary encryption key from the master node. The processor further locally generates the primary encryption key based at least in part on a combination of a primary seed value and an identifier that uniquely identifies the node on the wireless communications network. The processor further locally generates the secondary encryption key based at least in part on a combination of a secondary seed value and the identifier that uniquely identifies the node on the wireless communications network.
Patent NZ-594821-A (NZ)
Title: A reduced-cholesterol dairy product for use as a medicament
Inventor: DALEMANS DANIEL
IPC: A23K10/28
Filed: 2010-04-23
Abstract: Disclosed is the use of a cholesterol-reduced ruminant dairy product in the manufacture of a medicament for use in the treatment and/or the prevention of one or more conditions selected from cardiovascular disease, inflammatory disease, neurological disease, liver disease, or for decreasing the atherogenic ratio, or for increasing the poly-unsaturated fatty acids content in a mammal’s blood, or for decreasing the triglyceride content in a mammal’s blood, wherein the cholesterol content of the medicament is comprised between 10 mg/100g fat and 150 mg/100g fat.